Nurse Practitioner, Family · Moline, IL
NPI
1134883622
Since 2021
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
1409 25th St
Moline, IL, 61265
Phone (309) 737-8822
Groups this clinician bills Medicare through
Medicare paid, 2024
$84K
4,006 services
Medicare patients, 2024
233
Average age 75
Drug cost, 2024
$3.3M
5,806 prescriptions
Company payments, 2025
$708
From 13 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Melissa Caldwell was code J0897 (injection, denosumab, 1 mg), 1,440 times for 19 patients. In total Melissa Caldwell billed 4,006 services in 12 codes, and Medicare paid $84K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-10-29.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 1,440 | 19 | $20.83 | $30K |
| 99214 Office E&M - Established | Office | 402 | 212 | $80.69 | $32K |
| 95251 Test - Miscellaneous | Office | 170 | 86 | $22.62 | $3,845 |
| 96372 Injection Administration | Office | 60 | 24 | $8.98 | $539 |
| 99213 Office E&M - Established | Office | 31 | 24 | $55.02 | $1,705 |
| 83036 Blood Count | Office | 14 | 14 | $9.52 | $133 |
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83036 Blood Count | 14 | 14 | $9.52 | $133 |
Medicare prescription drug claims, 2024
In 2024, the drug Melissa Caldwell prescribed most often to Medicare patients was Levothyroxine Sodium, with 500 prescriptions and refills. In total Melissa Caldwell wrote 5,806 Medicare prescriptions that cost $3.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 500 | 1,333 | 157 | $4,538 |
| Atorvastatin Calcium Generic | 371 | 1,024 | 136 | $4,715 |
| Ozempic Semaglutide | 328 | 606 | 83 | $581K |
| Metformin Hcl Generic | 230 | 632 | 82 | $2,872 |
| Jardiance Empagliflozin | 197 | 486 | 70 | $275K |
| Mounjaro Tirzepatide | 196 | 252 | 37 | $267K |
| Ezetimibe Generic | 185 | 479 | 60 | $4,946 |
| Metformin Hcl Er Metformin Hcl | 169 | 429 | 54 | $1,989 |
| Farxiga Dapagliflozin Propanediol | 162 | 303 | 41 | $167K |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 159 | 462 | 68 | $22K |
| Tresiba Flextouch U-100 Insulin Degludec | 155 | 387 | 61 | $143K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 147 | 370 | 53 | $30K |
| Trulicity Dulaglutide | 141 | 234 | 39 | $232K |
| Humalog Kwikpen U-100 Insulin Lispro | 135 | 327 | 58 | $71K |
| Pioglitazone Hcl Generic | 114 | 278 | 36 | $1,377 |
Brand drugs: 2,978 claims; generic drugs: 2,343 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Melissa Caldwell $708 ($708 in general payments such as food, travel and fees) from 13 companies. The largest payer was Medtronic, Inc. with $145.
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. MDT | 5 | $145 |
| Lilly USA, LLC LLY | 11 | $129 |
| Amgen Inc. AMGN | 5 | $107 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 3 | $61.48 |
| Xeris Pharmaceuticals, Inc. | 3 | $50.51 |
| Radius Health, Inc. | 1 | $40.5 |
| Tandem Diabetes Care, Inc. TNDM | 2 | $40.49 |
| Averitas Pharma Inc. | 1 | $28.58 |
| Sequel Med Tech, LLC | 1 | $25.33 |
| Sandoz Inc. SDZ.SW | 1 | $22.33 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.